Redcare Pharmacy stock has results on October 29, 2026, slightly higher pre-market
Published on 10/28/2026 at 07:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming company dates
- Redcare Pharmacy’s investor-relations calendar schedules its Q3 2026 results release for October 29, 2026.
- The calendar lists a Baader Bank NDR for November 2, 2026.
- Redcare Pharmacy stock trades pre-market at EUR 78.28 at 7:37 a.m. CET at Lang & Schwarz on October 28, 2026, 0.42 percent above the Xetra close of October 27, 2026.
Redcare Pharmacy’s investor-relations calendar schedules its Q3 2026 results release and analyst and investor conference for October 29, 2026, according to Redcare Pharmacy. Redcare Pharmacy stock trades pre-market at EUR 78.28 at 7:37 a.m. CET at Lang & Schwarz on October 28, 2026, 0.42 percent above the Xetra close of October 27, 2026 (EUR 77.95).
Next company update
The October 29, 2026 event is listed as the company’s Q3 2026 interim statement and results publication, with an analyst and investor conference, on the investor-relations calendar. The same calendar lists a Baader Bank NDR for November 2, 2026. Redcare Pharmacy is the source for both dates.
Pre-market indication
The indication is EUR 0.33 above the Xetra close. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.
Business and market context
Redcare Pharmacy operates an online pharmacy serving the European market, according to its investor-relations website. Market context: Market report AEX.
